Search - tctmd.com

Displaying 341 - 360 of 373

Sort: Relevancy | Date

News Daily News

Genetic Testing Not Necessarily the Nail in the Coffin for HCM Diagnosis

Yael L. Maxwell

August 23, 2016

News Daily News

MI Patients Who Develop Heart Failure Vulnerable to Higher Risk of Cancer

Michael H. Wilson

July 13, 2016

News Daily News

FDA Warns of Class I Recall for HeartWare VAD Batteries

Michael O'Riordan

June 29, 2016

News Daily News

Si se Tomaran Más INRA, podrían Salvarle la Vida a Casi 30.000 Pacientes Cada Año

Michael H. Wilson

June 28, 2016

News Daily News

随着普及率的上升，ARNI 可能每年挽救近 3 万例患者

Michael H. Wilson

June 28, 2016

News Daily News

With Greater Uptake, ARNIs Could Potentially Save the Lives of Nearly 30,000 Patients Each Year

Michael H. Wilson

June 28, 2016

News Daily News

MitraClip for Obstructive Hypertrophic Cardiomyopathy? Small Series Raises Hopes

Shelley Wood

June 14, 2016

News Industry News

CVRx® Announces that the First Two Patients were Treated in the Phase III Pivotal Trial Evaluating BAROSTIM THERAPY® for the Treatment of Heart Failure

June 06, 2016

News Daily News

Abbott Buys St. Jude Medical for $25 Billion, Gaining More Muscle in Cardiovascular Device Arena

Michael O'Riordan

April 29, 2016

News Conference News ACC 2016

Vagus Nerve Stimulation Fails to Improve Clinical Outcomes in Chronic Heart Failure

Todd Neale

April 05, 2016

News Conference News ACC 2016

‘Enhanced’ Multicellular Stem Cell Therapy Improves Clinical Outcomes in Heart Failure: ixCELL-DCM Study

Michael O'Riordan

April 04, 2016

News Daily News

越来越多证据显示以肠促胰岛素类降糖药不会增加心衰风险

Michael O'Riordan

March 25, 2016

News Daily News

Evidence Mounts Showing No Increased Risk of Heart Failure With Incretin-Based Antidiabetic Drugs

Michael O'Riordan

March 25, 2016

News Daily News

Cada Vez Más Evidencias Confirman que No hay un Mayor Riesgo de Insuficiencia Cardíaca asociado a los Fármacos Antidiabéticos basados en la Incretina

Michael O'Riordan

March 25, 2016

News Daily News

比较分析表明无心衰患者使用 ACE 抑制剂和 ARB 类药物效果相当

Michael O'Riordan

January 19, 2016

News Daily News

Un Análisis Comparativo Sugiere que los Inhibidores de la ECA Equivalen a los ARB en Pacientes Sin Insuficiencia Cardíaca

Michael O'Riordan

January 19, 2016

News Daily News

Comparative Analysis Suggests ACE Inhibitors Equivalent to ARBs in Patients Without Heart Failure

Michael O'Riordan

January 19, 2016

News Daily News

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

December 23, 2015

News Industry News

BioControl Medical Completes Enrollment in the INOVATE-HF Study of the CardioFit® System to Treat Heart Failure

August 27, 2015

News Daily News

Bivalirudina + GPI Reduce las Hemorragias y Mortalidad de Pacientes con ICC sometidos a PCI

June 09, 2015

Advertisement

Genetic Testing Not Necessarily the Nail in the Coffin for HCM Diagnosis

MI Patients Who Develop Heart Failure Vulnerable to Higher Risk of Cancer

FDA Warns of Class I Recall for HeartWare VAD Batteries

Si se Tomaran Más INRA, podrían Salvarle la Vida a Casi 30.000 Pacientes Cada Año

随着普及率的上升，ARNI 可能每年挽救近 3 万例患者

With Greater Uptake, ARNIs Could Potentially Save the Lives of Nearly 30,000 Patients Each Year

MitraClip for Obstructive Hypertrophic Cardiomyopathy? Small Series Raises Hopes

CVRx® Announces that the First Two Patients were Treated in the Phase III Pivotal Trial Evaluating BAROSTIM THERAPY® for the Treatment of Heart Failure

Abbott Buys St. Jude Medical for $25 Billion, Gaining More Muscle in Cardiovascular Device Arena

Vagus Nerve Stimulation Fails to Improve Clinical Outcomes in Chronic Heart Failure

‘Enhanced’ Multicellular Stem Cell Therapy Improves Clinical Outcomes in Heart Failure: ixCELL-DCM Study

越来越多证据显示以肠促胰岛素类降糖药不会增加心衰风险

Evidence Mounts Showing No Increased Risk of Heart Failure With Incretin-Based Antidiabetic Drugs

Cada Vez Más Evidencias Confirman que No hay un Mayor Riesgo de Insuficiencia Cardíaca asociado a los Fármacos Antidiabéticos basados en la Incretina

比较分析表明无心衰患者使用 ACE 抑制剂和 ARB 类药物效果相当

Un Análisis Comparativo Sugiere que los Inhibidores de la ECA Equivalen a los ARB en Pacientes Sin Insuficiencia Cardíaca

Comparative Analysis Suggests ACE Inhibitors Equivalent to ARBs in Patients Without Heart Failure

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

BioControl Medical Completes Enrollment in the INOVATE-HF Study of the CardioFit® System to Treat Heart Failure

Bivalirudina + GPI Reduce las Hemorragias y Mortalidad de Pacientes con ICC sometidos a PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content